Rocket Pharmaceuticals Inc Forecast and Stock Analysis
Technical RCKT stock analysis for February 14, 2019.
Rocket Pharmaceuticals Inc gained 0.53% in the last trading day, rising from $15.02 to $15.10 The price has been going up and down for this period, and there has been a 5.01% gain for the last 2 weeks. Volume fell in the last day by -17 981 shares, and in total, 94 604 shares bought and sold for approximately $1.43 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
Close price at the end of the last trading day (Thursday, 14th Feb 2019) of the RCKT stock was $15.10. This is 0.53% more than the trading day before Wednesday, 13th Feb 2019.
During day the stock fluctuated 2.36% from a day low at $14.83 to a day high of $15.18.
30 day high of the RCKT stock price was $16.40 and low was $13.32.
90 day high was $16.95 and low was $10.75.
52 week high for the Rocket Pharmaceuticals Inc - $25.96 and low - $10.75.
Given the current horizontal trend you can expect Rocket Pharmaceuticals Inc with 90% probability to be traded between $11.40 and $16.63 at the end of this period with 90% probability. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the roof. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Rocket Pharmaceuticals Inc holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $15.05 and $15.06. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday February 13, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Relative Strength Index (RSI)
RSI14 is 50 and the stock is currently not being overbought or oversold
Support & Resistance
Rocket Pharmaceuticals Inc finds support from accumulated volume at $14.82.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.35 between high and low, or 2.36%. For the last week the stock has had a daily average volatility of 4.21%.
Our recommended stoploss: $14.22 (-5.81%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)
Very Low Low Medium High Very High
Evaluation: Buy Candidate
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for this stock to perform well in the short-term period.